header041509
Reference

Reference Material

Circulating Fetal Nucleic Acid Research

Y.M., LO. (2000). “Fetal DNA in maternal plasma: biology and diagnostic applications.” Clin Chem 46:1903-6.

LO, Y.M.D., ZHANG, J., LEUNG, T.N., LAU, T.K., CHANG, A.M., HJELM, N.M. (1999). “Rapid clearance of fetal DNA from maternal plasma.” Am. J Hum Genet 64:218-24.

LO, Y.M.D., TEIN, M.S., LAU. T.K., HAINES C.J., LEUNG, T.N., POON, P.M. (1998). “Quanatitive analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.” Am. J Hum Genet 62:768-75.

LO, Y.M.D., CORBETTA, N., CHAMBERLAIN, P.F., RAI, V., SARGENT, I.L., REDMAN, C.W. (1997). “Presence of fetal DNA in maternal plasma and serum.” Lancet 350:485-7.

 

RHD AND GENDER RESEARCH

GEIFMAN-HOLTZMAN, O., GROTEGUT, C.A., GAUGHAN, J.P. (2006). “Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood - A meta-analysis.” American Journal of Obstetrics and Gynecology 195:1163-73

FINNING, K.M., MARTIN, P.G., SCOOTHILL, P.W., AVENT, N.D. (2002). “Prediction of Fetal D Status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service.” Immunohemotology 42:1079-85

ZHONG, X.Y., HOLZGREVE, W., HAHN, S. (2001). “Risk free simultaneous prenatal identification of fetal rhesus D status and sex by multiplex Real-time PCR using cell free DNA in maternal plasma.” Swiss Med Wkly 131:70-14

LO, Y.M.D., HJELM, N.M., FIDLER, C., SARGENT, I.L., MURPHY, M.F., CHAMBERLAIN, P.F., POON, P.M., REDMAN C.M., WAINSCOAT, J.S. (1998). “Prenatal diagnostics of fetal RhD status by molecular analysis of maternal plasma.” N. Engi J Med 339:1734-8

 

TRISOMY RESEARCH

LO, Y.M.D., TSUI, N.B.Y., CHIU, R.W.K., LAU, T.K., LEUNG, T.N., HEUNG, M.S,M., GEROVASSILI, A., JIN, Y., NICOLAIDES, K.H., CANTOR, G. R., DING, C. (2007). “Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection.” Nature Medicine 13(2):218-23

TONG, Y.K., DING, G., CHIU, R.W.K., GEROVASSILI, A., CHIM, S.S.C., LEUNG, T.Y., LEUNG, T.N., L.AU, T.K., NICOLAIDES, K.H., LO, Y.M.D. (2006). “Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations.” Clin Chem 52:2194-2202

 

RHD CLINICAL OVERVIEW

P.I. CERRATO (2006). “The battle against Rh disease is about to get a lot easier.” Contemporary OB/GYN

WAGNER, F.F., AND W.A., FLEGEL (2004). “Review: The molecular basis of the Rh blood group phenotypes.” Immunohematology 20:23-5

Finning, K., Martin, P., Summers, J., Massey, E., Poole, G., Daniels, G. (2008). “Effect of high throughput RHD typing of fetal DNA in maternal
plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study.” British Medical Journal  -

 

LENETIX® Medical Screening Laboratory, Inc.
174 Mineola Blvd.  • Suite #1 •  Mineola, NY 11501
Tel: 516-320-6370  • Fax: 516-248-4436 •  Email: testing@lenetix.com •  website: www.lenetix.com

ReferenceBackBrochure

miniLENweb02

 

miniwebsedx02

RHD & SRY LINKS
RhD & SRY Genotyping

The Problem

The Solution

The Clinical Testing

The Sample Requirements

The Report(s)

The Flowchart

The Poster

 

Information on this site is intended for information purposes and is NOT a substitute for professional medical advise, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider for individual medical problem.

Copyright © 2003-2010 All rights reserved LENETIX® Medical Screening Laboratory, Inc. - privacy statement
need assistance